Digital Health Ecosystem for Oncology
Galen Growth is pleased to share with you our latest insights on Digital Health in Oncology. We define the boundaries of this important topic and explain the current trends in the market that are driving demand in the area. Our analysis focuses on private ventures and includes noteworthy partnerships, spotlight ventures, and venture funding.
HealthTech Alpha, a Galen Growth proprietary solution, powers this report!
- Oncology ventures dominated digital health landscape, raising the largest share of venture funding and forming numerous partnerships.
- Funding collapse in Q1 2023 knocked Oncology out of the top spot, overtaken by Neurology.
- Partnership activity remains strong, particularly in the Medical Diagnostics cluster.
- Regulatory filings for Oncology ventures were constant from 2021 to 2022, indicating a healthy ecosystem committed to generating evidence. Many ventures raised funds and are prepared for a potential venture capital drought.
About our Premium Reports
Our Premium Reports are specialized reports that are only available to active users with HealthTech Alpha Pro and HealthTech Alpha Enterprise accounts and are provided at no additional cost.
Source of Data
Galen Growth’s proprietary platform, HealthTech Alpha, provides the data source for this report. Corporate Business Development, Business Intelligence, and Digital Health Partnership teams worldwide prefer HealthTech Alpha, the world’s most-trusted Digital Health data, intel, and insights platform. Visit https://www.healthtechalpha.com/ to learn more about our data or https://www.galengrowth.com/research for our reports.
Founded in 2016 by Digital Health experts, Galen Growth empowers global Fortune 500 companies, institutional investors, and promising Digital Health ventures to fast track their digital health strategy to create significant financial and social values. To find out more, visit https://www.galengrowth.com/